APPLIKON Biotechnology is officially opening a facility located in Guangzhou, China, on March 19. A scientific seminar “Innovations in bioreactor technology” will be a highlight of the opening activities.
The grand opening will be attended by customers, business and institutional partners, and a large team of the Applikon Biotechnology headquarters in the Netherlands.
Located in ‘Science City’, a newly developed high tech science park in Guangzhou, the large premises consist of offices, a warehouse, production facilities, QA/QC testing section and a technical support department. While the facility has been operational for several months, the festivities planned on March 19 are intended to celebrate this achievement and to officially mark this further step in the development and growth of the company.
Arthur Oudshoorn, managing director of Applikon Biotechnology, believes that being closer to the customers in China will decrease response time and improve the local technical support for users of advanced bioreactor systems.
With the new facility, Applikon Biotechnology will be able to provide a complete range of bioreactor systems ranging from micro-liter research volumes intended for laboratory scale up to production systems for pharmaceutical and biotechnological applications in the Chinese market.Best Seller
Login/Register
Supplier Login
















